Table 4 Multivariable analysis of advanced adenoma detection rate (AADR) on initial screening colonoscopy performed on type 2 diabetes and non-diabetes patients.
From: Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy
Variable | Levels | Odds ratio | 95% CI | P-value |
|---|---|---|---|---|
Type 2 diabetes | Type 2 diabetes vs. non-diabetes | 1.28 | 0.85–1.93 | 0.24 |
BMI kg/m² | Every 1 unit increase | 1.03 | 1.01–1.05 | 0.0096 |
Smoking | Current vs. Never | 1.94 | 1.34–2.81 | 0.0019 |
Current vs. Quit | 1.62 | 1.09–2.42 | ||
Age (y) | Every 1 year increase | 1.05 | 1.03–1.08 | <0.0001 |
Sex | Male vs Female | 2.4 | 1.79–3.22 | <0.0001 |
Race | Black/AA vs. White/EA | 0.83 | 0.47–1.5 | 0.55 |
Asian vs. White/EA | 0.45 | 0.14–1.47 | ||
Other vs. White/EA | 0.89 | 0.36–2.18 | ||
Hispanic | Hispanic vs. non-Hispanic | 0.6 | 0.3–1.2 | 0.15 |
Family History of CRC | History vs. no history | 1.16 | 0.64–2.13 | 0.62 |
Aspirin use | Yes vs No | 0.74 | 0.49–1.11 | 0.15 |
Quality of colonoscopic prep | Good vs. Excellent | 1.32 | 0.92–1.9 | 0.33 |
Fair vs. Excellent | 0.98 | 0.49–1.97 | ||
Undocumented vs. Excellent | 1.56 | 0.82–2.94 | ||
Fellow Involvement | Yes vs. No | 1.11 | 0.78–1.58 | 0.58 |
Insurance | Commercial vs. Medicare | 1.13 | 0.71–1.8 | 0.24 |
Commercial vs. Medicaid | 0.72 | 0.5–1.04 | ||
Commercial vs. Self-Pay | 0.63 | 0.25–1.59 |